Questions About Cancer? 1-800-4-CANCER

Recovery Act Funding Announcements

NCI encourages the cancer research community to apply for grants supported by the American Recovery and Reinvestment Act of 2009 (ARRA).

Helpful information for submitting ARRA applications can be found at the NCI FAQs and NIH FAQs pages. Please review these useful information resources in preparing your ARRA submissions.

Find information about NCI's implementation of the recovery act at www.cancer.gov/recovery.

New opportunities will be added as they become available. Please check back frequently for updates.

NIH Administrative Notices regarding Recovery Act funding
 
Updated: March 23, 2010
Title: Recovery Act: Update on ARRA Quarterly Reporting Requirements for Non-Competing Continuation Awards and Relinquished Projects; and Guidance to Avoid Common Errors
Announcement Number:
NOT-OD-10-065
Release Date:
March 19, 2010
Receipt Date:
n/a
Description: The purposes of this Guide Notice are to: 1) provide ARRA quarterly reporting guidance for NIH non-competing continuation awards; 2) provide guidance on reporting requirements for relinquished/transferred ARRA grants; and 3) help grantees avoid some common errors identified in previous reporting periods.
Title: Recovery Act: Reminders on Annual Reporting Requirements and Notice of Revised Financial Closeout Requirements for ARRA-funded Administrative Supplements and Competitive Revisions
Announcement Number:
NOT-OD-10-066
Release Date:
March 17, 2010
Receipt Date:
n/a
Description: The purposes of this Guide Notice are to: 1) remind NIH grantees that information on ARRA-funded Administrative Supplements and Competitive Revisions must be included in the annual progress report of the parent grant; 2) remind grantees on the special reporting requirements for administrative supplements providing summer experiences for students and science educators; and 3) inform grantees of revised financial closeout requirements when multiple ARRA-funded Administrative Supplements and/or Competitive Revisions are awarded to the same parent award.
Title: Recovery Act: Notice on the Proper Management of Recovery Act Spending to Promote Job Creation and Increase the Pace of Scientific Research; and Policy Limiting Second No-Cost Extensions to Recovery Act Grants
Announcement Number:
NOT-OD-10-067
Release Date:
March 17, 2010
Receipt Date:
n/a
Description: The purposes of this Guide Notice are to: 1) reaffirm to NIH grantees that the primary  goals of all NIH Recovery Act awards are to create U.S. jobs and increase the tempo of biomedical research; 2) remind Project Directors/Principal Investigators (PD/PIs) and grantee institutions that NIH fully expects Recovery Act grantees to expend funds in a timely and expeditious manner in accordance with the expected pace of research; 3) remind grantees that all Recovery Act expenditures remain subject to terms and conditions on the Notice of Award, including the NIH-HHS Standard Terms and Conditions for ARRA Awards (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-120.html) and all referenced regulations and OMB Circulars; and 4) notify grantees that NIH expects all grant activities are to be completed consistent with the schedule of the approved project period.  While the NIH Terms of Award provide for extending the final budget period of a project period for up to twelve months to allow for completion of the planned project; prior approval requests for additional extensions will only be considered in very limited circumstances.
Closed Announcements
Find closed announcements for all categories, including Challenge Grants, Grand Opportunities, and Core Center grants.
Updated: June 22, 2010

Administrative Notices
Title: Regarding Competitive Revisions Using Recovery Act Funds for Applications Still Requiring Paper Submission
Announcement Number:
NOT-OD-09-083
Release Date:
April 10, 2009
Receipt Date:
n/a (Closed)

Description: Guidance to applicants responding to NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications (NOT-OD-09-058) that are competitive revisions for arrafunding-parent awards for which the activity code of the application has not transitioned to electronic submission. This includes Program Project grants (P01), Center grants (e.g., P20, P30, P50), Cooperative Agreements (e.g., U01), Training Grants (e.g., T32) and Institutional Career Development Awards (K12).

As indicated in the notice, two additional copies of the application (e.g., P01, P30, P50, U01, U10, etc.), which will be submitted on paper, should be sent to NCI as indicated below:

Referral Officer
Division of Extramural Activities
National Cancer Institute (NCI)
6116 Executive Blvd., Rm. 8041, MSC 8329
Bethesda, MD 20892-8329 (for U.S. Postal Service Express or regular mail)
Rockville, MD 20852 (for express/courier delivery)
Phone: 301-496-3428
E-mail: ncirefof@dea.nci.nih.gov

In a brief cover letter, please mention NOT-OD-09-058, which is the relevant funding opportunity announcement, the NCI-funded arrafunding-parent grant number, and the assigned NCI program director.

Title: Recovery Act Notice: NIH ARRA Funding Considerations for Applications with Meritorious Scores that Fall Beyond the Pay-line
Announcement Number:
NOT-OD-09-078
Release Date:
April 3, 2009
Receipt Date:
n/a (Closed)

Description: NIH will implement ARRA to select existing peer-reviewed, meritorious grant applications, that can be accomplished in two years or less, meet the goals of the ARRA, and meet the mission priorities of NIH.

NCI will only be considering FY 2009 applications. Applications submitted in response to NCI RFAs and Program Announcements with specific set-asides (PAS) that have already been considered and not selected for funding, will not be reconsidered for ARRA funding.


Recovery Act Limited Competition
Title: Participation of NCI in RFA-OD-10-001, ARRAOS: Recovery Act Limited Competition: Behavioral Economics for Nudging the Implementation of Comparative Effectiveness Research: Clinical Trials (RC4)
Announcement Number:
NOT-CA-10-012
Release Date:
January 12, 2010
Receipt Date:
April 7, 2010 (Closed)
Description: The National Cancer Institute (NCI) invites applications proposing clinical trials using the principles of behavioral economics to enhance the uptake of the results of comparative effectiveness research (CER) among health care providers in their practice. Applicants must propose controlled trials that randomize units (whether individuals or clusters such as practices, hospitals, or larger units) to conditions, resulting in a randomized clinical trial or cluster randomized trial. The definition of CER will adhere to that adopted by the Federal Coordinating Council given at http://www.hhs.gov/recovery/programs/cer/cerannualrpt.pdf and behavioral economics refers to the interdisciplinary efforts involving cognitive and social psychologists, decision scientists, and other social scientists together with economists to model economic decision-making and consequent actions.
Title: Notice of Limited Competition Availability of Recovery Act Funds for NCMHD Competitive Revision Applications to Support Comparative Effectiveness Research for Eliminating Disparities (CERED)
Announcement Number:
NOT-MD-10-002
Release Date:
February 2, 2010
Receipt Date:
April 6, 2010 (Closed)
Description: The National Center on Minority Health and Health Disparities n partnership with the Office of Minority Health, Office of Public Health and Science, Department of Health and Human Services announces the availability of $7.0 million in FY 2010 for institutions/organizations with active NCMHD-supported Exploratory Centers of Excellence (P20) and Comprehensive Centers of Excellence (P60) grants to submit revision applications (formerly termed competitive supplements) to support the establishment of Centers of Excellence for conducting Comparative Effectiveness Research for Eliminating Disparities. The definition of comparative effectiveness research will adhere to that adopted by the Federal Coordinating Council, which can be found at http://www.hhs.gov/recovery/programs/cer/execsummary.html.
Title: Recovery Act Limited Competition: Institutional Comparative Effectiveness Research Mentored Career Development Award (KM1)
Announcement Number:
RFA-OD-10-011
Release Date:
January 13, 2010
Receipt Date:
March 25, 2010 (Closed)
Description: The National Institutes of Health (NIH) invites applications from research-intensive institutions to support mentored career development in support of comparative effectiveness research (CER) in an interdisciplinary environment catering to the needs of diverse populations of scholars including (but not limited to) those with backgrounds in biostatistics, epidemiology, health economics, pharmacology, medicine, and dentistry. Scholars should be encouraged to register for higher degrees, where appropriate. Successful applicant institutions will be expected to include course development work in their proposal and make provision for expanding the pool of experienced CER mentors.
Title: Participation of NCI in RFA-OD-10-002, ARRAOS: Recovery Act Limited Competition: Behavioral Economics for Nudging the Implementation of Comparative Effectiveness Research: Pilot Research (RC4)
Announcement Number:
NOT-CA-10-013
Release Date:
January 12, 2010
Receipt Date:
March 19, 2010 (Closed)
Description: The National Cancer Institute (NCI) invites applications to study how the principles of behavioral economics could be used to enhance the uptake of the results of comparative effectiveness research (CER) among health care providers in their practice. Applications should be thought of as large pilot or preliminary studies rather than definitive trials. This funding opportunity seeks applications that will investigate whether the principles of behavioral economics could be used to enhance the uptake of the results CER among health care providers and also enhance the maintenance of such treatments in patient populations. The definition of CER will adhere to that adopted by the Federal Coordinating Council given at http://www.hhs.gov/recovery/programs/cer/cerannualrpt.pdf and behavioral economics refers to the interdisciplinary efforts involving cognitive and social psychologists, decision scientists, and other social scientists together with economists to model economic decision-making and consequent actions.
Title: Recovery Act Limited Competition: NIH Director's Opportunity for Research in Five Thematic Areas (RC4)
Announcement Number:
RFA-OD-10-005
Release Date:
December 28, 2009
Receipt Date:
March 15, 2010 (Closed)
Description: The NIH has established a program entitled "NIH Director's Opportunity for Research in Five Thematic Areas". This program will support projects that address research endeavors in specific areas that will benefit from significant three-year funds without the expectation of continued NIH funding beyond this period. The research supported by the program should have high short-term impact, and a high likelihood of enabling growth and investment in biomedical research and development, public health, and health care delivery, Proposals should include development implementation of critical research innovations in one or more of the following five thematic areas: applying genomics and other high throughput technologies; translating basic science discoveries into new and better treatments; using science to enable health care reform; focusing on global health; and reinvigorating the biomedical research community.
Title: Participation of NCI in RFA-OD-10-008, Recovery Act Limited Competition: Comparative Effectiveness Research on Upper Endoscopy in Gastroesophageal Reflux Disease (GERD), Eradication Methods for Methicillin Resistant Staphylococcus aureus (MRSA), and Dementia Detection and Management Strategies (RC4)
Announcement Number:
NOT-CA-10-014
Release Date:
January 12, 2010
Receipt Date:
February 26, 2010 (Closed)
Description: The National Cancer Institute (NCI) invites applications to conduct preliminary comparative effectiveness research (CER) projects in targeted, high-priority areas in which such efforts have been lacking. Applications should be thought of as large pilot or preliminary studies rather than definitive trials. The definition of comparative effectiveness research will adhere to that adopted by the Federal Coordinating Council given at http://www.hhs.gov/recovery/programs/cer/execsummary.html.
Title: Recovery Act Limited Competition: Methodology Development in Comparative Effectiveness Research (RC4)
Announcement Number:
RFA-OD-10-009
Release Date:
December 28, 2009
Receipt Date:
February 26, 2010 (Closed)
Description: The National Institutes of Health (NIH) invites applications to enhance, develop, or evaluate methodologies to improve the efficiency, validity, and credibility of comparative effectiveness research (CER) studies. Research in methodology development focuses on approaches to design, implement, analyze, and report CER, as opposed to CER projects that focus on comparing specific interventions for preventing or treating a given medical condition. It is hoped that this line of research will lead to significantly greater efficiency, validity, and credibility of CER among researchers, health care providers, and policy makers, and therefore will enhance the quality of the nation's health. The definition of CER will adhere to that adopted by the Federal Coordinating Council given at http://www.hhs.gov/recovery/programs/cer/cerannualrpt.pdf.

NIH Limited Competition Opportunities for Small Businesses
Title: Recovery Act Limited Competition: NIH Basic Behavioral and Social Science Opportunity Network (OppNet) Short-term Mentored Career Development Awards in the Basic Behavioral and Social Sciences for Mid-career and Senior Investigators (K18)
Announcement Number:
RFA-OD-10-003
Release Date:
January 5, 2010
Receipt Date:
February 18, 2010 (Closed)
Description: NIH invites applications for short-term mentored career development (K18) awards in the basic behavioral and social sciences research (b-BSSR). The program targets established, mid-career and senior investigators, to support development of research capability in b-BSSR. Two categories of candidates are targeted: (a) biomedical or clinical researchers with little experience in basic behavioral and social sciences research seeking training with a well established b-BSSR investigator to explore the introduction of b-BSSR into their research programs; and (b) investigators in the basic or applied behavioral and social sciences seeking to build new components or domains of basic-BSSR into their research programs. This funding is not intended as a substitute for research project support.
Title: Recovery Act Limited Competition: Building Sustainable Community-Linked Infrastructure to Enable Health Science Research (RC4)
Announcement Number:
RFA-OD-09-010
Release Date:
September 18, 2009
Receipt Date:
December 11, 2009 (Closed)

Description: NIH solicits applications from domestic (United States) institutions/organizations proposing to support the development, expansion, or reconfiguration of infrastructures needed to facilitate collaboration between academic health centers and community-based organizations for health science research. Such collaboration should transform the way in which health science research is conducted in communities, and accelerate the pace, productivity, dissemination, and implementation of health research.

This initiative is one of several being offered by the NIH to help fulfill the goals of the American Recovery and Reinvestment Act (ARRA) to help stimulate the economy through support of biomedical and behavioral research. For more information see Building Sustainable Community-Linked Infrastructure to Enable Health Science Research (RC4)

Title: Recovery Act Limited Competition: Biomedical Research, Development, and Growth to Spur the Acceleration of New Technologies (BRDG-SPAN) Pilot Program (RC3)
Announcement Number:
RFA-OD-09-008
Release Date:
June 2, 2009
Receipt Date:
September 1, 2009 (Closed)

Description: This award will utilize the RC3 grant mechanism. The purpose of this pilot program is to address the funding gap between promising research and development (R&D) and transitioning to the market by contributing to the critical funding needed by applicants to pursue the next appropriate milestone(s) toward ultimate commercialization. This program also aims to foster partnerships among a variety of R&D collaborators. NIH intends to commit at least $35 million to support at least 10 awards in fiscal year, but awards are contingent upon the availability of funds. Budget proposals should be limited to $1 million total costs per year for a maximum of three years.

This program is related in scope to the prior NCI SBIR Phase II Bridge Program (RFA-CA-08-021) where the scope of applications has been limited to cancer therapeutics and cancer imaging technologies. In contrast, for the BRDG-SPAN Pilot Program, applications will be considered in any technical area that is relevant to the mission of the NCI. See NIH RFA notice for submission requirements.

NCI Scientific/Research Contact
Mr. Michael Weingarten
Program Manager
National Cancer Institute (NIH)
31 Center Drive
Room 10A52
Bethesda, MD 20892
Phone: 301- 496-1550
Fax: 301- 496-7807
E-mail: mw498z@nih.gov

Organizations MUST Register in Both Grants.gov and eRA Commons
to Apply for Most NIH Grants.
Registration can take approximately 4 weeks to complete. Start now!
Title: Recovery Act Limited Competition: Small Business Catalyst Awards for Accelerating Innovative Research (R43)
Announcement Number:
RFA-OD-09-009
Release Date:
June 2, 2009
Receipt Date:
September 1, 2009 (Closed)

Description: This award will use the Phase I SBIR (R43) award mechanism. The purpose is to invite grant applications from small businesses that propose to accelerate innovation through high risk, high reward research and development (R&D) that has commercial potential and is relevant to the mission of the NIH. Solicited applications for support for projects that have the potential to generate high impact results (e.g., products, processes or services) and/or innovative research applications, research tools, techniques, devices, inventions, or methodologies. In accord with the funding priority of this initiative to attract applicants without a history of SPIR/STTR support from NIH, the focus of the projects solicited by the FOA is on early stage technology development. NIH intends to commit at least $5 million to make approximately 20-25 awards for fiscal year 2010. Budget requests are limited to $200,000 total costs for a maximum project period of one year. See NIH RFA notice for additional information on eligibility and submission requirements.

Organizations MUST Register in Both Grants.gov and eRA Commons
to Apply for Most NIH Grants.
Registration can take approximately 4 weeks to complete. Start now!

NIH National Center on Minority Health and Health Disparities (NCMHD) Awards
Title: Recovery Act Limited Competition: NCMHD Community Participation in Health Disparities Intervention Research Planning Phase (R24)
Announcement Number:
RFA-MD-09-006
Release Date:
May 12, 2009
Receipt Date:
June 30, 2009 (Closed)
Description: The NIH National Center on Minority Health and Health Disparities (NCMHD) annouces a funding opportunity to support intervention research on health disparities that is jointly conducted by communities and researchers.
Title: Recovery Act Limited Competition: NCMHD Exploratory Centers of Excellence (P20)
Announcement Number:
RFA-MD-09-007
Release Date:
May 12, 2009
Receipt Date:
July 1, 2009 (Closed)
Description: The NIH National Center on Minority Health and Health Disparities (NCMHD) annouces a funding opportunity to eligible institutions/organizations that propose to establish an Exploratory NCMHD Center of Excellence (COE) that will provide funding for hiring staff, researchers, community members, and trainees with the goal of augmenting and expanding the capacity and infrastructure of the institution and community to engage in research improving the health of nation and for preparing the next generation of researchers.
Title: Recovery Act Limited Competition: NCMHD Dissertation Research Award to Increase Diversity (R36)
Announcement Number:
RFA-MD-09-008
Release Date:
May 12, 2009
Receipt Date:
June 30, 2009 (Closed)
Description: The NIH National Center on Minority Health and Health Disparities (NCMHD) annouces a funding opportunity to support qualified pre-doctoral students to pursue research careers in any area relevant to the research mission of the NCMHD (i.e., minority health and health disparities research) and simultaneously increase the diversity of this workforce.

Challenge Grants
Title: Recovery Act Limited Competition: NIH Challenge Grants in Health and Science Research (RC1)
Announcement Number:
RFA-OD-09-003
Release Date:
March 4, 2009
Receipt Date:
April 27, 2009 (Closed)
Description: The NIH Challenge Grants in Health and Science Research will support new projects that address specific biomedical, behavioral and public health research challenges. There is one RFA for the Challenge Grants but many scientific topics that applications might address. Learn more about NCI's Challenge Grants topics at http://challenge.nci.nih.gov.

Organizations MUST Register in Both Grants.gov and eRA Commons
to Apply for Most NIH Grants.
Registration can take approximately 4 weeks to complete. Start now!
Grand Opportunities (GO)
Title: Recovery Act Limited Competition for NIH Grants: Research and Research Infrastructure "Grand Opportunities" (RC2)
Announcement Number:
RFA-OD-09-004
Release Date:
March 20, 2009
NEW Receipt Date:
May 29, 2009 (Closed)
Note: The application deadline has been extended due to maintenance of the eRA Commons Web site. However, applications may be submitted to Grants.gov during this time (May 22-26).

Description: The Research and Research Infrastructure Grand Opportunities (GO) program will support high-impact, large-scale projects that lend themselves to short-term, non-renewable funding. NCI expects to devote $10,000,000 to support projects in areas such as nanotechnology, proteomics, stem cell research, early phase clinical trials, transcriptional and translational regulation, and comparative oncology research. See the following NCI announcements:
Organizations MUST Register in Both Grants.gov and eRA Commons
to Apply for Most NIH Grants.
Registration can take approximately 4 weeks to complete. Start now!
Core Center Grants (P30)
Title: Recovery Act Limited Competition: Biomedical Research Core Centers to Enhance Research Resources (P30 - faculty recruitment)
Announcement Number:
RFA-OD-09-005
Release Date:
March 24, 2009
Receipt Date:
May 29, 2009 (Closed)
Description: This award is designed to support Core Center Grants. This program will provide funding to develop the resources necessary to conduct relevant research projects, including funds for hiring and providing appropriate start-up packages for newly-independent investigators. NCI expects to make up to a total of 10 awards with funding of approximately $8 million in total costs each year for the two year period FY2009 and FY2010. See NIH grant application guidelines for NCI Core Centers for Enhancing Research Capacity In U.S. Academic Institutions (P30).

Two additional (paper) copies of the application should be sent to the NCI at the address shown below:

Referral Officer
Division of Extramural Activities
National Cancer Institute (NCI)
6116 Executive Blvd., Rm. 8041, MSC 8329
Bethesda, MD 20892-8329 (for U.S. Postal Service Express or regular mail)
Rockville, MD 20852 (for express/courier delivery)
Phone: 301-496-3428
E-mail: ncirefof@dea.nci.nih.gov
Instrumentation
Title: Recovery Act Limited Competition: High-End Instrumentation Grant Program (S10)
Announcement Number:
PAR-09-118
Release Date:
March 5, 2009
Receipt Date:
May 6, 2009 (Closed)
Description:Groups of NIH-supported investigators may request funds to purchase a single major item of equipment to be used for biomedical research that costs at least $600,000. The maximum award is $8,000,000.
Title: Addition of Recovery Funds to the Shared Instrumentation Grant Program
Announcement Number:
PAR-09-028
Release Date:
November 14, 2008
Receipt Date:
March 23, 2009 (Closed)
Description:This funding opportunity encourages applications for shared instrumentation and other capital research in the range of $100,000 to $500,000.
NIH Academic Research Enhancement Awards (AREA)
Title: Recovery Act Limited Competition: Academic Research Enhancement Award (R15)
Announcement Number:
RFA-OD-09-007
Release Date:
April 20, 2009
Receipt Date:
(Earliest) August 24, 2009
(Final) September 24, 2009
(Closed)
Description: The purpose of the NIH Academic Research Enhancement Award (AREA) program is to stimulate research in educational institutions that provide baccalaureate or advanced degrees for a significant number of the Nation's research scientists, but that have not been major recipients of NIH support. These AREA grants create opportunities for scientists and institutions otherwise unlikely to participate extensively in NIH programs, to contribute to the Nation's biomedical and behavioral research effort. AREA grants are intended to support small-scale, health-related research projects proposed by faculty members of eligible, domestic institutions. See NIH RFA notice for additional information on eligibility and submission requirements.
Competitive Revisions and Administrative Supplements
Title: Administrative Supplements for The Cancer Genome Atlas (TCGA) Program
Announcement Number:
NOT-OD-09-056
Release Date:
May 28, 2010
Receipt Date:
June 21, 2010 (Closed)
Description: Those with active TCGA funding through RFA-CA-09-010 may apply for an administrative supplement to support the acceleration of the analysis and characterization of genetic alterations within more than 20 types of cancers. See NCI Guidelines for Administrative Supplements for The Cancer Genome Atlas (TCGA) Project (PDF 41KB).
Title: Administrative Supplements for The Cancer Genome Atlas (TCGA) Pilot Project
Announcement Number:
NOT-OD-09-056
Release Date:
May 1, 2009
Receipt Dates:
June 1, 2009, and June 1, 2010 (Closed)
Description: Those with NCI-funded research projects may apply for an administrative supplement in support of The Cancer Genome Atlas (TCGA) to accelerate the analysis of genetic alterations in glioblastoma, ovarian, lung, and other cancer types. See NCI Guidelines for Administrative Supplements for The Cancer Genome Atlas (TCGA) Pilot Project (PDF 34KB).
Title: NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications (R01, R03, R15, R21, R21/R33, and R37) for HIV/AIDS-related Research through the NIH Basic Behavioral and Social Science Opportunity Network (OppNet)
Announcement Number:
NOT-OD-10-033
Release Date:
January 7, 2010
Receipt Date:
March 25, 2010 (Closed)
Description: The National Institutes of Health (NIH) announces the opportunity for investigators and United States institutions/organizations with relevant active NIH-supported research project grants (R01, R03, R15, R21, R21/33, and R37) to submit competitive revision applications (formerly termed competitive supplements) to accelerate, expand, and/or strengthen basic behavioral and social sciences research (b-BSSR) relevant to HIV/AIDS risk, prevention, and treatment. Competitive revision applications must support a significant expansion of the scope or research protocol approved and funded for the "parent" award on which the revision application is based.
Title: NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications for Small Business Innovation Research and Small Business Transfer Technology Research Grants (R43/R44 and R41/R42) through the NIH Basic Behavioral and Social Science Opportunity Network (OppNet)
Announcement Number:
NOT-OD-10-034
Release Date:
January 7, 2010
Receipt Date:
March 25, 2010 (Closed)
Description: The National Institutes of Health (NIH) announces the opportunity for investigators and United States institutions/organizations with relevant active NIH-supported small business research project grants (STTR [R41, R42], SBIR [R43, R44], and SBIR/STTR Fast-Track grants) to submit competitive revision applications (formerly termed competitive supplements) to accelerate innovation through basic behavioral and social science research (b-BSSR) and development that has commercial potential and is relevant to the mission of OppNet (http://oppnet.nih.gov). Competitive revisions must focus on b-BSSR that has the potential to accelerate results (e.g., products, processes or services) and/or includes innovative research tools, techniques, devices, inventions, or methodologies. Competitive revision applications must support a significant expansion of the scope or research protocol approved and funded for the "parent" small business award on which the revision application is based.
Title: NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications (R01, R03, R15, R21, R21/R33, and R37) through the NIH Basic Behavioral and Social Science Opportunity Network (OppNet)
Announcement Number:
NOT-OD-10-032
Release Date:
January 7, 2010
Receipt Date:
March 2, 2010 (Closed)
Description: The National Institutes of Health (NIH) announces the opportunity for investigators and United States institutions/organizations with relevant active NIH-supported research project grants (R01, R03, R15, R21, R21/33, and R37) to submit competitive revision applications (formerly termed competitive supplements) to accelerate, expand, and/or strengthen basic behavioral and social sciences research (b-BSSR). Competitive revision applications must support a significant expansion of the scope or research protocol approved and funded for the "parent" award on which the revision application is based.
Title: Recovery Act Limited Competition: Administrative Supplements for Re-engineering Protocol Implementation and Development (RaPID) of Phase 1 to 3 Cancer Protocols Conducted by Eligible NCI U10-Supported Cooperative Groups and NCI U01-Supported Cancer Radiology Networks
Announcement Number:
NOT-CA-09-056
Release Date:
December 30, 2009
Receipt Date:
January 22, 2010 (Closed)
Description: These Administrative Supplements are available to institutions with active NCI U10-supported Cooperative Groups (U10) and NCI U01-Supported Cancer Radiology Network (U01) under which Phase 1 to 3 cancer clinical trials are conducted. The purpose of the administrative supplements is to improve the timelines involved in activating NCI-sponsored Phase 1 to 3 trials in accordance with the recommendations of the NCI Operational Efficiency Working Group (OEWG). More Specific Information follows
Title: NIH Announces the Availability of Recovery Act Funds for Administrative Supplements to Support Core Consolidation
Announcement Number:
NOT-RR-10-001
Release Date:
November 6, 2009
Receipt Date:
January 13, 2010 (Closed)
Description: The National Institutes of Health (NIH) announces the opportunity for investigators and United States institutions/organizations with certain active NIH Research Grants that support core facilities to request administrative supplements for the purpose of consolidating multiple cores into a single, more efficient core. A core facility is defined as a centralized shared resource that provides access to instruments, technologies, services, as well as expert consultation to biomedical or behavioral investigators. This is a broad definition that covers instrument intensive facilities as well as facilities that offer advice concerning experimental design or data interpretation.
Title: NIH Announces the Availability of Recovery Act Funds for Administrative Supplements
Announcement Number:
NOT-OD-09-056
Release Date:
March 16, 2009
Receipt Date:
See guidelines for specific NCI program receipt dates.
Description: Those with active NIH research grants may request administrative supplements to accelerate the tempo of scientific research on active grants. Specific areas of interest include: equipment purchases, increasing clinical trials enrollment and capacity for data analysis, research employment opportunities, and comparative effectiveness research. NCI will also be accepting supplement requests solely for small equipment (<$100K) purchases. See the National Cancer Institute (NCI) Guidelines for ARRA Administrative Supplements.
Title: Administrative Supplements for Patient Navigators for the Cancer Care Continuum
Announcement Number:
n/a
Release Date:
May 11, 2009
Receipt Date:
July 1, 2009 (Closed)
Description: Those with NCI-funded research projects may apply for an administrative supplement announced by the Center to Reduce Cancer Health Disparities (CRCHD) for a patient navigator who helps guide patients through the medical care system. Applications are limited to those with NCI funding through the CRCHD from the following programs: Minority Institutions/Cancer Center Partnership (MI/CCP), the Community Networks Program (CNP). See NCI Guidelines for Administrative Supplements for Patient Navigators for the Cancer Care Continuum (PDF 52KB).
Title: Administrative Supplements for a Community Health Educator (CHE) for Outreach, Education, Coordination, and Evaluation
Announcement Number:
n/a
Release Date:
May 11, 2009
Receipt Date:
July 1, 2009 (Closed)
Description: Those with NCI-funded research projects may apply for an administrative supplement announced by the Center to Reduce Cancer Health Disparities (CRCHD) for a community health educator. Applications are limited to those with NCI funding through the Center to Reduce Cancer Health Disparities (CRCHD) from the following programs: Minority Institutions/Cancer Center Partnership (MI/CCP), the Community Networks Program (CNP), and the Patient Navigation Research Program (PNRP). See NCI Guidelines for Administrative Supplements for a Community Health Educator (CHE) for Outreach, Education, Coordination, and Evaluation (PDF 51KB).
Title: Administrative Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers
Announcement Number:
NOT-OD-09-056
Release Date:
May 1, 2009
Receipt Date:
July 1, 2009 (Closed)
Description: Those with NCI-funded research projects may apply for an administrative supplement announced by the Center to Reduce Cancer Health Disparities (CRCHD) to encourage individuals with high potential to re-enter an active research career after a qualifying interruption for family or other responsibilities. See NCI Guidelines for Administrative Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (PDF 35KB).
Title: Administrative Supplements for Minority Biospecimen/Biobanking - Geographic Management Program (BMaP)
Announcement Number:
n/a
Release Date:
April 13, 2009
Receipt Date:
July 1, 2009 (Closed)
Description: Those with NCI-funded research projects may apply for an administrative supplement to create state-of-the art networks/centers dedicated to ensuring the adequate and continuous supply of high-quality human biospecimens from multi-ethnic communities for cancer research. Applications are limited to those with funding through the Center to Reduce Cancer Health Disparities (CRCHD) from the following programs: Minority Institutions/Cancer Center Partnership (MI/CCP), the Community Networks Program (CNP), and the Patient Navigation Research Program (PNRP). See NCI Guidelines for Administrative Supplements for Minority Biospecimen/Biobanking - Geographic Management Program (BMaP) (PDF 108KB).
Title: Administrative Supplements for Transdisciplinary Geographic Management Program (GMaP)
Announcement Number:
n/a
Release Date:
April 13, 2009
Receipt Date:
July 1, 2009 (Closed)
Description: Those with NCI-funded research projects may apply for an administrative supplement to create state-of-the art regional networks/centers dedicated to cancer health disparities research and care. Applications are limited to those with NCI funding through the Center to Reduce Cancer Health Disparities (CRCHD) from the following programs: Minority Institutions/Cancer Center Partnership (MI/CCP), the Community Networks Program (CNP), and the Patient Navigation Research Program (PNRP). See NCI Guidelines for Administrative Supplements for Transdisciplinary Geographic Management Program (GMaP) (PDF - 106KB).
Title: Administrative Supplements for Emerging Technologies Continuing Umbrella of Research Experiences (ET CURE)
Announcement Number:
n/a
Release Date:
April 13, 2009
Receipt Date:
July 1, 2009 (Closed)
Description: Those with NCI-funded research projects may apply for an administrative supplement announced by the Center to Reduce Cancer Health Disparities (CRCHD) to plan and implement a research training program to provide research training in emerging technologies (ET-CURE) for high school and undergraduate students from underserved populations. See NCI Guidelines for Administrative Supplements for the Emerging Technologies Continuing Umbrella of Research Experiences (ET CURE) (PDF - 240KB).
Title: NCI Administrative Supplements for SBIR/STTR Workforce Enhancements to Accelerate the Commercialization of Novel Cancer-Related Innovations
Announcement Number:
NOT-OD-09-056
Release Date:
April 6, 2009
Receipt Date:
June 30, 2009 (Closed)
Description: Those with active NCI SBIR/STTR Phase II awards are encouraged to apply for administrative supplements. However, SBIRs/STTRs are only eligible for administrative supplements to create employment opportunities that will accelerate the commercialization of novel cancer-related products. See NCI Guidance for Administrative Supplements for SBIR/STTR Workforce Enhancements to Accelerate the Commercialization of Novel Cancer-Related Innovations.
Title: Administrative Supplements in Support of Expanding the Childhood Cancer TARGET Initiative
Announcement Number:
NOT-OD-09-056
Release Date:
May 11, 2009
Receipt Date:
June 12, 2009 (Closed)
Description: Those with active NIH research grants may apply for administrative supplements that will support expansion of The Childhood Cancer Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative to include additional pediatric cancers as well as furthering our understanding of treatment failure for acute lymphoblastic leukemia and neuroblastoma. The primary focus of the TARGET Initiative will remain identifying genomic alterations that offer rapid pathways to novel therapeutic interventions that may lead to more effective treatments. See NCI Guidelines for Administrative Supplements in Support of Expanding the Childhood Cancer TARGET Initiative (PDF 69KB).
Title: Administrative Supplements for NCI Alliance for Nanotechnology in Cancer Grants and Cooperative Agreements
Announcement Number:
NOT-OD-09-056
Release Date:
May 5, 2009
Receipt Date:
June 1, 2009 (Closed)
Description: Those with active NIH research grants may apply for administrative supplements that will support efforts in the use of nanomaterials, nanotechnology tools, and devices towards applications in prevention, diagnosis, and therapy of cancer through specifically targeting job creation and retention through pursuing cancer proteomics research currently being conducted under funding of these awards. See NCI Guidance for Administrative Supplements for NCI Alliance for Nanotechnology in Cancer Grants and Cooperative Agreements (PDF 36KB).
Title: Administrative Supplements for NCI Clinical Proteomic Technologies for Cancer Program
Announcement Number:
NOT-OD-09-056
Release Date:
May 4, 2009
Receipt Date:
June 1, 2009 (Closed)
Description: Those with active NIH research grants may apply for administrative supplements that will support the application of proteomic technologies in discovering and verifying biomarkers of early cancer detection and therapeutic outcomes through specifically targeting job creation and retention through pursuing cancer proteomics research currently being conducted under funding of these awards. See NCI Guidance for Administrative Supplements for NCI Clinical Proteomic Technologies for Cancer Program (PDF 32KB).
Title: Administrative Supplements for Recruitment of New Faculty in NCI Designated Cancer Centers (P30) and in Minority Serving Institutions Funded through the U54 Comprehensive Minority Institution/Cancer Center Partnership
Announcement Number:
n/a
Release Date:
April 2, 2009
Receipt Date:
May 15, 2009 (Closed)
Description: NCI-designated Cancer Center Directors and Minority Serving Institutions (MSI) principle investigators, funded through the Comprehensive Minority Institution/Cancer Center Partnership program, are invited to apply for an administrative supplement to hire new faculty to strengthen their cancer research programs. This supplement is limited to hiring of physician-scientist who are newly independent or mid-career researchers. See NCI Guidelines for Administrative Supplement for Recruitment of New Faculty in NCI Designated Cancer Centers (P30) and in Minority Serving Institutions Funded through the U54 Comprehensive Minority Institution/Cancer Center Partnership (PDF 78KB) and P30/U54 Faculty Initiatives Frequently Asked Questions (40KB).
Title: NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications
Announcement Number:
NOT-OD-09-058
Release Date:
March 18, 2009
Receipt Date:
April 21, 2009 (Closed)
Description: Those with active NIH research grants may submit revision applications to support a significant expansion of scope or research protocol. Examples of the types of revisions may include addition of students, postdoctoral fellows, principal investigators, or other personnel as well as investments in technology essential to expand the goals of the project. Institutes have specific guidelines for applying for these funds; see the National Cancer Institute (NCI) Guidelines for ARRA Competitive Revisions. See also the National Center for Research Resources (NCRR) for NCRR specific application guidelines.

Released April 10, 2009: Notice NOT-OD-09-083 Competitive Revisions Using Recovery Act Funds for Applications Still Requiring Paper Submission for arrafunding-parent awards for which the activity code of the application has not transitioned to electronic submission.

As indicated in the NOT-OD-09-083 notice, two additional copies of the application (e.g., P01, P30, P50, U01, U10, etc.), which will be submitted on paper, should be sent to NCI as indicated below:

Referral Officer
Division of Extramural Activities
National Cancer Institute (NCI)
6116 Executive Blvd., Rm. 8041, MSC 8329
Bethesda, MD 20892-8329 (for U.S. Postal Service Express or regular mail)
Rockville, MD 20852 (for express/courier delivery)
Phone: 301-496-3428
E-mail: ncirefof@dea.nci.nih.gov

In a brief cover letter, please mention NOT-OD-09-058, which is the relevant funding opportunity announcement, the NCI-funded arrafunding-parent grant number, and the assigned NCI program director.

Title: NCI-Activities to Promote Research Collaborations (Administrative Supplements)
Announcement Number:
n/a
Release Date:
March 17, 2009
Receipt Date:
May 1, 2009 (Closed)
Description: Those with NCI-funded research projects may apply for funding to support new multidisciplinary scientific collaborations among NCI grantees, as well as with other members of the scientific community, in cancer biology, cancer control and population sciences, cancer surveillance, cancer prevention, health services and outcomes research, and cancer treatment and diagnosis. See also NCI- APRC Guidelines and Information for Applicants (PDF - 65KB).
Title: NIH Announces the Availability of Recovery Act Funds for Administrative Supplements Providing Summer Research Experiences for Students and Science Educators
Announcement Number:
NOT-OD-09-060
Release Date:
March 18, 2009
Receipt Date:
April 27, 2009 (Closed)
Description: Those with active NIH research grants may request administrative supplements to encourage students to pursue research careers in the health-related sciences, as well as provide elementary, middle, and high school teachers, community college faculty, and faculty from non-research institutions with short-term research experiences in NIH-funded laboratories. See the National Cancer Institute (NCI) Guidelines for ARRA Administrative Supplements Providing Summer Research Experiences for Students and Science Educators.
Title: Administrative Supplement for Early Phase Imaging in Therapeutic Clinical Trials - Cancer Imaging Program
Announcement Number:
n/a
Release Date:
April 29, 2009
Receipt Date:
May 27, 2009 (Closed)
Description: Those with NCI-funded research projects may apply for an administrative supplement to support early phase advanced imaging in therapeutic clinical trials under approved protocols or protocols that will be approved shortly that address the following scientific areas: 1) development of FLT-PET as a predictive marker in cancer therapy of solid-tumors, 2) NaF-PET as a pharmacodynamic biomarker, or 3) application of USPIOs to direct brain cancer therapy. Projects that address scientific areas 1 and 2 above should be ready for expansion to a multi-site study. Applicants are limited to those with existing grants under the U01, U10 (Cooperative Group Program), R01, P01, P30 (Cancer Center Support Grant) mechanisms. See NCI Guidelines for Administrative Supplements in Support of Early Phase Imaging in Therapeutic Clinical Trials- Cancer Imaging Program (PDF 208KB).
Construction/Renovation
Title: Recovery Act Limited Competition: Core Facility Renovation, Repair, and Improvement (G20)
Announcement Number:
RFA-RR-09-007
Release Date:
March 5, 2009
Receipt Date:
September 17, 2009 (Closed)
Description: These funds support renovations, repairs, or improvements to Public Health Service core facilities that support biomedical and/or behavioral research. A core facility is defined as a centralized, shared resource that provides access to instruments or technologies or services, as well as expert consultation to investigators supported by the facility.
Title: Recovery Act Limited Competition: Extramural Research Facilities Improvement Program (C06)
Announcement Number:
RFA-RR-09-008
Release Date:
March 5, 2009
Receipt Date:
May 6, 2009 (Closed)
Description: Those with active NIH research grants may request administrative supplements to accelerate the tempo of scientific research on active grants. Specific areas of interest include: equipment purchases, increasing clinical trials enrollment and capacity for data analysis, research employment opportunities, and comparative effectiveness research.

For financial and grants management-related questions or inquiries please contact:

Office of Grants Administration (OGA)
Crystal Wolfrey, Grants Branch Chief
Grants Management Specialist, OGA
National Cancer Institute, NIH, HHS
Telephone: 301-496-8634
Fax: 301-846-5720
E-mail: wolfreyc@mail.nih.gov

Back to TopBack to Top